All posts by imreal

Lane Health and United Care Consortium Establish Strategic Partnership to Help Unlock Healthier Futures


“We’re thrilled to partner with United Care Consortium to help make healthcare more accessible and help their clients’ employees better manage their out-of-pocket healthcare costs,” said Scott Beck, Chief Revenue Officer at Lane Health.

Lane Health and United Care Consortium announced today they have entered into an agreement for Lane Health to provide their innovative benefit spending account solutions to United Care Consortium clients. Through this strategic partnership, United Care Consortium clients can offer their employees Lane Health’s health savings accounts (HSAs), flexible spending accounts (FSAs) and Commuter accounts, as well as the groundbreaking Advance¹ line of credit, issued by WebBank.

“We’re thrilled to partner with United Care Consortium to help make healthcare more accessible and help their clients’ employees better manage their out-of-pocket healthcare costs,” said Scott Beck, Chief Revenue Officer at Lane Health. “United Care Consortium shares our dedication to constant innovation and exceptional client and employee service, and this alignment will enable us to drive powerful and positive change to clients’ employee benefits programs together.”

Lane Health’s HSAs and FSAs come with an Advance line of credit, which, once activated, provides employees with additional funds when their spending account funds are exhausted. Employees can repay Advances and associated fees in smaller pieces over 12 months, and employees with HSAs have the ability to repay with pre-tax funds and gain tax savings. Also, there is no credit risk for United Care Consortium clients to make the Advance line of credit available to their employees through Lane Health’s spending accounts.

“We’re constantly seeking ways to offer even more value to our clients and their employees, and we’re confident our strategic partnership with Lane Health will provide real and meaningful benefits to both,” said Derek Lodholtz, Founder and Alliance Director at United Care Consortium. “With the Advance line of credit, our clients can help provide their employees greater peace of mind, knowing they can have a helping hand paying for healthcare expenses when they need it.”

About Lane Health

Lane Health can help make healthcare more affordable and accessible through unique, integrated capabilities to deploy capital into the healthcare delivery system exactly when members need it most. Lane Health’s combination of proprietary technology solutions, personalized service, and innovative product lineup positions the company at the forefront of the healthcare and FinTech juncture. Lane Health’s industry trailblazing and rapid growth through broker and strategic partner distribution has been recognized with the Alegeus APEX Awards in 2021, 2022 and 2023. Visit http://www.LaneHealth.com to learn more.

About United Care Consortium

The United Care Consortium makes sense of today’s rollercoaster that is employer-sponsored health plans. The United Care Consortium was founded on the ideology that there is a better way to finance healthcare costs and has successfully created a model available to employers. The United Care Consortium specializes in innovative methods to keep costs down for both employers and their employees. With medical discounts often exceeding 70%, pharmacy savings that exceed 40% for most clients, plan surplus refund eligibility, ACA compliance, and consortium grouping benefits amongst other unique strategies – no stone was left unturned in the process of developing the IDEAL health plan. The United Care Consortium is available in all 50 states and typically distributes through exclusivity agreements with select brokerages/agencies.

Share article on social media or email:

Since Dobbs, millions visit Power to Decide’s ‘AbortionFinder’ website to obtain accurate information about where to get abortion care


“In the midst of so much uncertainty and misinformation, AbortionFinder gives people accurate information about abortion options so they can make informed decisions and access the care they need.”— Raegan McDonald-Mosley, MD, MPH

Since the U.S. Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision, abortion access has been banned or restricted in nearly half of the United States. Since the decision was leaked, Power to Decide’s AbortionFinder, an online search tool for people seeking abortion care, experienced a more than 543% increase in visits.

“The chaos and confusion about abortion caused by the Dobbs decision is harmful and threatens reproductive health,” said Power to Decide CEO and practicing OBGYN Raegan McDonald-Mosley, MD, MPH. “In the midst of so much uncertainty and misinformation, AbortionFinder gives people accurate information about abortion options so they can make informed decisions and access the care they need.”

Launched in September 2020, AbortionFinder is a resource that aims to reduce barriers to abortion care by addressing abortion seekers’ needs. The site helps people seeking abortion find verified abortion care based on their location, age and pregnancy stage. AbortionFinder is built upon a comprehensive directory of trusted, verified abortion providers and assistance resources in the United States. The site is regularly updated as state policies change and provides medically accurate information about abortion options, with detailed state-by-state guides available in both English and Spanish.

Since June 24, 2022, there have been over 4 million visits to AbortionFinder. Prior to that, AbortionFinder had 777,000 visits from September 2020 to May 2022. The sharp increase in AbortionFinder visits reflects both the urgent need for abortion care across the U.S. and the growing confusion about abortion options and access. (Note: Due to confidentiality, AbortionFinder only tracks the number of visitors; no personal information about site visitors is collected.)

“Those numbers put the magnitude of the reproductive health crisis and the importance of our work into perspective,” said McDonald-Mosley. “We are passionate about helping to ensure that all people have access to the reproductive health care they need and want, including abortion.”

###

Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live, or what their economic status might be—have the power to decide if, when and under what circumstances to get pregnant or have a child.

Share article on social media or email:

Warm Hands, Hopeful Hearts Project Aims for a Close-Knit Community


Renal Support Network (RSN) is excited announce Warm Hands, Hopeful Hearts, a new community building program bringing people together to help those who have kidney disease and are on dialysis.

RSN’s Warm Hands, Hopeful Hearts project is all about engaging with the community by making a gift for someone on dialysis. Fingerless gloves, or mittens as they are sometimes called, are a thoughtful, useful gift because people on dialysis get cold during a treatment.

Why do people on dialysis feel cold during treatment? Anemia is one cause and many people who have kidney disease experience a low hemoglobin. In addition, during a 3-4 hour hemodialysis treatment there is about a pint of blood that is circulating in the tubing through the dialysis machine. People on dialysis often report they feel cold. The fingerless gloves will allow them to be on their smart phone or tablet and keep their hands covered and warm.

RSN is calling on all crafters in the kidney community and the general public across the country to get involved. This program is not just for individuals. This is also an ideal project for groups to participate in, whether it be a group of friends or coworkers. RSN also encourages corporate decision makers to make Warm Hands. Hopeful Hearts their company team building, or charitable project.

There are patterns and tutorials available on the website, but anyone can make gloves in any style they like with whatever materials they prefer working with. The gloves can be knitted, crocheted, or sewn. You can use a new pair of socks or repurpose an old sweater for materials. Anything goes!

At the beginning of the year, RSN partnered with Notre Dame High School in Sherman Oaks for a multi-day volunteer event where RSN was able to educate the Notre Dame students on kidney disease, dialysis, and transplantation. The students then had the opportunity to make their own fingerless gloves out of socks that they had donated to our project. We finished this partnership with 542 donated socks to be turned into gloves, and 251 finished packs ready to be sent to a dialysis center! The packs included a pair of gloves and a nice note from the student who made them.

“I needed a new project for my office after-hours crafting group, and this is perfect!” – Laura B.

“I always wanted to do something meaningful for my community, but I wasn’t sure how. This program allows me to put my crafting skills to good use helping others.” – Bonny B.

“I have so much yarn that I never know what to do with but keep it around just for something like this. I’m excited to get started on my gloves for this program.” – Kate C.

“This is a refreshing new team building project for my company. I put my non-crafty team members in charge of collection sweaters, socks and other materials we could use. Then my craftier people got to work making mittens!” – Catherine G.

The finished gloves will be collected and distributed to dialysis centers across the country with a short, inspiring note from the maker. Each center will distribute a pair to a person on dialysis. To learn more about program and find tutorial to make fingerless gloves, visit %20https:/https://www.rsnhope.org/rsns-warm-hands-hopeful-heart-project/.

—————————————————————————————–

The Renal Support Network (RSN) is a nonprofit organization founded by Lori Hartwell in 1993. RSN’s hopeful and life-enriching programs help people, and their families deal with kidney disease, whether they are in the early stages of the disease, on dialysis, or have had a transplant. Hartwell’s mission is to help them cope and give them hope. Hartwell suffered kidney failure at the age of 2. She survived 50-plus surgeries and was on dialysis for 13 years. She is now living with her fourth kidney transplant. Hartwell founded RSN to encourage her peers to develop the skills and knowledge necessary to navigate this illness. To this day, Hartwell continues to serve as president of RSN, the leading organization in engaging people who have kidney disease through its vast reach and prolific library of documented patient experiences. Visit http://www.RSNhope.org to learn more.

Share article on social media or email:

SightMD Announces Industry-Leading Net Promoter Score of 84


News Image

“Our mission at SightMD is to provide the very best in eye care, both medically and surgically.” Said Jeffrey Martin, MD “Hearing that we have achieved an excellent report from our patients is the ultimate in satisfaction as a provider. We will continue to strive to be even better.”

SightMD, a leading multi-specialty ophthalmology platform is proud to announce that it has received a Net Promoter Score (NPS) of 84, based on a survey of over 5,750 patients since the survey launched in Q4 of 2022. Net Promoter Score is a customer experience metric that measures loyalty and is predictive of business growth. NPS is calculated by asking an initial survey question on a 0–10 rating scale. Then, the accumulated ratings are graded as one number between -100 and 100. This number expresses how customers perceive a company. A score of 84 is considered to be among the absolute best in their industry and is a testament to the high level of satisfaction that SightMD’s patients have with the practice.

“Our mission at SightMD is to provide the very best in eye care, both medically and surgically.” Said Jeffrey Martin, MD Co-Founder and President of SightMD “Hearing that we have achieved an excellent report from our patients is the ultimate in satisfaction as a provider. We will continue to strive to be even better.”

Through the survey patients reported high levels of satisfaction with SightMD’s team of doctors as well as its clinical staff. “SightMD is the best!! The team of highly skilled doctors are intelligent, highly knowledgeable, who are also very patient. They listen to you and answer all the questions you may have. Their team is confident in what they are doing and gives you confidence as well.” said one patient from Long Island. Survey responses also praised the company’s support teams, noting that they were “informative and quick to respond.”

“Our role as administrative provider is to support our eye doctors so they can provide the greatest patient care experience.” said Jonathan Lujan CEO of Sight Growth Partners “NPS scores above 80 are considered world-class. I am proud that we can help provide world-class experiences for the physicians we support and their patients.”

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

About Sight Growth Partners

Sight Growth Partners is the leading administrative services provider for the ophthalmology sector including SightMD in New York, SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. It has over 140 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory surgery centers. Sight Growth Partners provides its clients with world-class administrative services, including a 24/7 call center, billing, credentialing, marketing, human resources, and other services, enabling them to continue delivering best-in-class care to patients in their communities. Sight Growth Partners is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about Sight Growth Partners, please visit http://www.sightgrowthpartners.com.

Share article on social media or email:

Caring Transitions Extends Compassionate Care to San Diego


“Being newer to San Diego, I wanted to be involved with the community and I feel like this is a way I can help give back.”

Caring Transitions, the leader in senior relocation and transition services, continues to expand its compassionate reach across the nation with its latest location. Caring Transitions of San Diego East is owned and operated by Wade Pantel and opened for business June 1st.

Caring Transitions is a franchise designed to minimize stress by utilizing specially trained professionals to oversee every detail of a senior’s transition with compassion, including decluttering, organizing, packing, move management, unpacking, resettling, and cleanouts. The company also manages both in-home and online estate sales. The online estate sales are hosted on CTBIDS, the brand’s widely popular auction platform, which can support its clients in liquidating unique and everyday treasures that many cherish.

A management consultant for 18 years, Wade has always looked for new business opportunities and knew San Diego was the place to start his own when he moved there two years ago. The Texas-native was familiar with Caring Transitions, as his grandparents and mother used their services several years ago in College Station, Texas. The new franchisee admitted he loved what the business had to offer and feels like he can also help and grow with the community he loves.

“It’s a valuable business that serves a need to be filled, especially for the senior population,” Wade said. “It’s something that I can grow a business while also giving back to a segment that needs it. Being newer to San Diego, I wanted to be involved with the community and I feel like this is a way I can help give back.”

Caring Transitions currently has more than 280 franchise locations serving families across the country.

“Wade certainly has a passion for not only helping those who may be looking to re-organize or downsize their living situation, but also create a space for those looking for items with our CT Bids offering,” said Ray Fabik, President of Caring Transitions. “It’s clear that he is determined to immerse himself and lend a hand to his community and we’re excited to watch him grow with this latest location.”

To learn more about Caring Transitions, visit http://www.CaringTransitions.com.

For more about franchising opportunities with Caring Transitions, visit https://www.caringtransitionsfranchise.com/.

About Caring Transitions

Caring Transitions, founded in 2006, is the most trusted and experienced national franchise specializing in senior relocation and transition services. With more than 280 locations throughout the United States, all owned and operated by Certified Relocation and Transition Specialists, Caring Transitions provides clients with supportive moves, auctions, rightsizing, and transitions. This includes expert advice plus a well-executed transition plan beginning with the initial sorting of personal belongings through packing, unpacking, resettling, and selling of items to the final clearing and cleaning of the property. For more information, visit http://www.caringtransitions.com or visit us on Facebook.

Share article on social media or email:

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure


News Image

“Our HIV clinical trial has produced a successful Phase 1 for our single-infusion gene therapy, AGT103-T. Now we’re launching a new company, Addimmune, to accelerate our research and continue to pursue our mission to cure HIV. – AGT CEO Jeff Galvin

American Gene Technologies (AGT™), a clinical-stage biotechnology company based in Rockville, Maryland, is launching a new company — Addimmune — to continue to develop gene and cell therapy technologies to cure HIV. Addimmune will focus solely on advancing an HIV cure, building upon more than a decade of work by AGT that led to a successful Phase 1 HIV gene and cell therapy clinical trial.

Addimmune aims to create tremendous benefits for HIV patients, payers, and the public. Its gene therapy technology has the power to transform millions of lives. The new company’s name represents a fusion of two fundamental concepts: using gene and cell therapy to add new capacity to the human T cell to create an improved immune system to fight HIV.

Addimmune is founded on the solid legacy established by AGT.

  • Spinning off the HIV components into a separate company enables Addimmune to focus its resources on the Phase 2 and Phase 3 clinical trials.
  • The Phase 2 clinical trial will optimize the regimen for an expanded trial, treating fifty to one hundred patients with the intention to firmly establish efficacy levels that justify a pivotal study. If successful, upcoming additional clinical trials could allow Addimmune to continue towards commercialization and the goal of providing improved outcomes and quality of life for people living with HIV.

“I founded American Gene Technologies fifteen years ago in the wake of the Human Genome Project, inspired by scientific discoveries in viral vectors and other technological advancements in gene and cell therapy. I saw a future where modifying DNA would lead to treatments and cures for formerly intractable diseases. Fast forward to today, our HIV clinical trial has produced a successful Phase 1 for our single-infusion gene therapy, AGT103-T. Now we’re launching a new company, Addimmune, to accelerate our research and continue to pursue our mission to cure HIV. We feel the market is receptive to this mission, data, and potential. Additional capital and a laser focus on HIV will align our company with the hopes and needs of the HIV community and maximize our chance of success,” explained American Gene Technologies CEO, Jeff Galvin.

American Gene completed the Phase 1 HIV clinical trial and submitted the final report to the U.S. Food and Drug Administration (FDA). Internal data from the HIV Phase 1 clinical trial demonstrated the following results:

  • 100% of the participants experienced no serious adverse events.
  • 100% of the participants’ modified T cells were engrafted, expanded after infusion, and maintained reactivity to HIV.
  • There was no rejection of the cells that continued to be detected in patients, even without exposure to the virus, until final study measurements at 180 days.
  • There were no differences in safety between the low-dose and high-dose treatment arms.

Data about this first-in-human study was published in November 2022 in Frontiers in Medicine, a peer-reviewed scientific journal focused on medical advancement.

After completing the Phase 1 human trial, American Gene Technologies conducted a sponsor-initiated study with approval from the Independent Review Board (IRB) and clinical trial investigators to test the therapy’s efficacy after cessation of patients’ antiretroviral treatment.

Despite the relatively long time between the infusion of the HIV cure cell therapy and the analytic treatment interruption study, AGT still measured impressive viral and immunological data in participants absent the typically prescribed antiretroviral treatment drugs:

  • 100% of the participants showed active immune responses to HIV.
  • The data showed that more than half of the participants achieved significant viral suppression.

AGT scientists continue to analyze the data to fully understand the mechanisms underlying these findings.

About Addimmune

Addimmune was founded in 2023 to cure HIV with promising gene therapy technologies. Building upon the success of American Gene Technologies’ HIV clinical trial, Addimmune is solely focused on developing and commercializing an effective and lasting cure for HIV. Learn more about Addimmune in this video: https://www.youtube.com/watch?v=xFQVfUtiYQc

About American Gene Technologies

American Gene Technologies is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of gene therapies to cure infectious diseases, cancers, and inherited disorders. Its mission is to transform people’s lives through genetic medicines that rid the body of disease. Safety data from American Gene Technologies’ Phase 1 HIV gene therapy clinical trial is published in the Frontiers in Medicine journal. In addition, the company has been granted broad patent protection for the technology used to make AGT103-T. Numerous other patents have been granted for its unique immuno-oncology approach to stimulate gamma-delta (γδ) T cells to destroy a variety of solid tumors, as well as other important innovations and discoveries that are useful across a wide variety of gene and cell therapy applications. American Gene Technologies has developed a synthetic gene for treating Phenylketonuria (PKU), a debilitating inherited disease. The company’s treatment for PKU has been granted Orphan Drug Designation by the Food and Drug Administration (FDA), and it is expected to reach the clinic in 2025.

Share article on social media or email:

Amerisure’s Atlanta Location Named Among the Best and Brightest Companies to Work For®


“This recognition is a testament to the passion of our Atlanta-area team, and their ability to work together to continuously deliver exceptional service,” said Ben Nichols, Amerisure’s regional vice president of Field Marketing and Underwriting for the Central region.

Amerisure Insurance has once again been recognized among Atlanta’s Best and Brightest Companies to Work For®. This year marks the eighth time Amerisure’s Atlanta service center has been named to the prestigious list for the Atlanta area. The program identifies and honors organizations that display a commitment to excellence in human resource practices and employee enrichment.

The 2023 award recipients were evaluated based on key workplace categories, including communication; work-life balance; employee education; diversity, equity and inclusion; achievement and recognition; and retention. Only companies that “distinguish themselves as having the most innovative business acumen and human resource practices can be bestowed this honor,” according to the program requirements.

“We’re excited to once again be recognized for the outstanding work culture fostered by our employees and we congratulate our Atlanta team for their proven dedication,” said Ben Nichols, Amerisure’s regional vice president of Field Marketing and Underwriting for the Central region. “This recognition is a testament to the passion of our Atlanta-area team, and their ability to work together to continuously deliver exceptional service.”

The annual Best and Brightest competitions are sponsored by The National Association for Business Resources (NABR). All of the 2023 winning organizations will be invited to attend an exclusive national conference for winners across the country. This year’s conference will be held on September 27-28 in Detroit, Michigan.

Amerisure’s Metro Detroit headquarters has also been awarded the Best and Brightest recognition for 2023. To see the full list of recipients or learn more about the award, click here.

About Amerisure Insurance

Amerisure is a leading provider of commercial property and casualty insurance solutions for U.S.-based construction, manufacturing and healthcare businesses. Licensed in all fifty states and available through an exclusive network of elite independent agents, the company upholds an “A” (Excellent) financial strength rating, industry-leading service scores, and multiple awards for innovation. Amerisure has been in business for more than 100 years and is consistently named among the best places to work in the industry and throughout the nation. To learn more, visit amerisure.com.

Share article on social media or email:

Nisum Partners With CharmHealth To Deliver Innovative Healthcare Solutions and Patient Insights


Nisum, a global digital consulting firm specializing in digital transformation and IT services, and CharmHealth, a leading provider of comprehensive healthcare technology solutions, are thrilled to announce their strategic partnership. This collaboration brings together the expertise of two industry leaders to deliver innovative healthcare solutions and drive digital transformation in the healthcare sector.

Nisum, with its extensive experience in digital consulting and IT services, has a proven track record of assisting organizations across various industries in their digital transformation journeys. Their commitment to delivering tailored solutions and fostering business agility aligns perfectly with CharmHealth’s mission to provide comprehensive healthcare technology solutions.

CharmHealth is recognized for its advanced and user-friendly electronic health record (EHR) system, designed to streamline workflows and improve patient care. With a focus on providing end-to-end healthcare solutions, CharmHealth’s platform encompasses electronic medical records (EMR), practice management, revenue cycle management, telehealth, and more.

Nisum has been an exceptional ally in the healthcare industry, consistently delivering innovative custom solutions that have transformed large medical practices and health verticals. This strategic partnership between CharmHealth and Nisum signifies a profound commitment to delivering better patient outcomes and pushing the boundaries of innovation in healthcare. Their motto, ‘Building Success Together®,’ resonates deeply with our own values and philosophy.

-Venky Chellappa, CharmHealth+ Bioverge Digital Health Venture Fund

Through this strategic partnership, Nisum and CharmHealth aim to revolutionize the healthcare industry by combining their respective expertise. Clients of both organizations can look forward to the following benefits:

Comprehensive Healthcare Solutions

The partnership will result in the development of advanced and integrated healthcare solutions covering a wide range of functionalities. This will enable healthcare providers to streamline their operations, improve patient outcomes, and enhance overall efficiency.

Digital Transformation

Nisum’s expertise in digital transformation, coupled with CharmHealth’s cutting-edge healthcare technology solutions, will empower healthcare organizations to embrace digital innovation and accelerate their transformation journeys.

Customization and Scalability

Clients will benefit from tailored solutions that address their unique needs. Nisum and CharmHealth will work closely with healthcare providers to understand their specific requirements and deliver scalable solutions that evolve alongside their organizations.

Seamless Integration

By leveraging their combined technological capabilities, Nisum and CharmHealth will facilitate the seamless integration of healthcare systems, enabling interoperability and data exchange between different platforms.

Our partnership with CharmHealth co-creates scalable, cloud data based, bespoke healthcare technology solutions. This isn’t just a partnership, it’s a pledge to transform healthcare provider operations and craft personalized patient experiences, through digital innovation.

-Ravi Narayanan, VP and Global Leader – Data & Analytics

Contact a Nisum expert today to build and implement a data transformation strategy customized for your business.

About Nisum

Nisum is a renowned global digital consulting firm headquartered in Silicon Valley. With a team of 2,000 professionals spread across North America, Latin America, India, and Pakistan, Nisum brings over 20 years of industry experience in digital strategy and engineering, insights and analytics, blockchain, customer experience, business agility, and software development. As a trusted advisor to leading Fortune 500 brands, Nisum empowers businesses across diverse sectors to foster innovation, boost agility, and elevate customer experiences.

Share article on social media or email:

U.S. Dermatology Partners Announces the Opening of Wichita Falls, Texas Office


Dermatology Clinic in Wichita Falls Texas

U.S. Dermatology Partners Wichita Falls

“Thanks to the U.S. Dermatology Partners’ Outreach Program, we have been able to offer our premier dermatological services to underserved communities, and now, we are excited to expand our talented teams into Wichita County,” said Paul Singh, CEO of U.S. Dermatology Partners.

U.S. Dermatology Partners is pleased to announce the opening of its newest office location in Wichita Falls, Texas. The new office is part of the organization’s Outreach Program serving rural and underserved communities and will offer convenient access to dermatology and skin cancer treatments to patients in Wichita County beginning June 12th. The office will treat patients of all ages for a range of dermatologic conditions including acne, psoriasis, eczema, and skin cancer.

Access to essential dermatological care can be a challenge for patients seeking treatment in rural areas due to extended wait times or the need to travel long distances to reach the nearest practitioners. To alleviate this burden, U.S. Dermatology Partners is launching more than 30 new locations across eight states. These new offices, including the one in Wichita Falls, will provide patients in rural areas with more convenient access to the care they need and deserve. The Wichita Falls location will be led by Dermatology Experienced Certified Family Nurse Practitioner Khadeen Patrick, under the supervision of Board-Certified Dermatologist Dr. Clint Moss.

“Thanks to the U.S. Dermatology Partners’ Outreach Program, we have been able to offer our premier dermatological services to underserved communities, and now, we are excited to expand our talented teams into Wichita County,” said Paul Singh, CEO of U.S. Dermatology Partners. “Our new office will provide preventive care options, enhance well-being and enable the early detection of serious issues like skin cancer for more manageable treatment. We look forward to working with members of the community as partners in safeguarding their health.”

Wichita Falls is the county seat of Wichita County and is comfortably nestled in the North-East corner of the Panhandle/Plains area of North Texas. With a population of over 104,000, this family-oriented city is conveniently located within two hours of two metropolitan areas with populations each exceeding one million citizens: Dallas-Fort Worth and Oklahoma City. Wichita Falls is home to Sheppard Air Force Base, a major training center for air force technicians, a flight training center for NATO, and the city’s largest employer. When it comes to fun, Wichita Falls prides itself on having something for everyone. You’ll find considerable cultural activities from the symphony to an authentic Texas rodeo. Additionally, residents of Wichita Falls enjoy the wonderful twenty-mile-long trail system that winds through neighborhoods and along attractive streams and lakes for use by walkers, joggers, bicycles, and rollerbladers and an additional parks system featuring 39 parks within the city limits.

Today’s announcement builds on U.S. Dermatology Partners’ recent openings of offices in Forney, Texas, Muskogee, Oklahoma, and Cushing, Oklahoma, which expand on their efforts to reach more patients while delivering the same high-quality care, throughout the country.

The new Wichita Falls office is conveniently located at 3916 Call Field Road, #300, Wichita Falls, TX 76308. Patient appointments are available year-round. The Wichita Falls office accepts Medicare and Medicare Supplement programs and most national medical insurances including Blue Cross Blue Shield, United Healthcare, Cigna, and Aetna, as well as regional insurances including Amerigroup.

For more information or to schedule an appointment, call (940) 464-5922 or click here to request an appointment online.

About U.S. Dermatology Partners

U.S. Dermatology Partners is one of the premier dermatology practices in the country, caring for more than 1.5 million patients each year. With over 100 locations across eight states that span large metroplexes and rural, underserved communities, they provide the benefits of private, personalized levels of care paired with a network of coordinated, specialized dermatology physicians. U.S. Dermatology Partners is fervently focused on providing the highest level of compassionate and comprehensive patient-first care, making it seamless for all people to connect with dermatologists and national leaders in areas such as clinical research, psoriasis, and Mohs surgery, and gain access to state-of-the-art dermatological treatments, surgical and cosmetic dermatology. To learn more, visit usdermatologypartners.com.

Share article on social media or email:

Producing High Quality CRISPR-Cas9 Edited hiPSCs for Cardiac Disease Modeling, Upcoming Webinar Hosted by Xtalks


The featured speakers used a stirred suspension bioreactor system to create an optimal environment for cell growth and differentiation.

The Nobel prize winning discovery of human induced pluripotent stem cells (hiPSCs) facilitated a new era of disease modeling in vitro. This event inspired clinicians and scientists alike to use those cells for regenerative medicine, or for modeling of genetic diseases, to gain further insights into disease mechanisms on a cellular level. However, experimental studies using hiPSCs can experience high inter- and intra-experimental variability further fueling the reproducibility crisis in life sciences.

In the past 10 years much progress has been made in defining quality criteria (QC) for hiPSCs to achieve genome stability and high pluripotency over prolonged culture duration. These QC parameters include single cell clonal selection, karyotyping, pluripotency assessment and the establishment of master cell banks, especially in the context of CRISPR-Cas9 genome edited hiPSCs. Additionally, Numerous cardiac differentiation protocols have been established using monolayer (ML) adherent or 3D suspension cultures. However, generating large numbers of high quality human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) with high consistency between batches, different cell lines and cryo-storage has remained challenging leading to poor reproducibility of experimental results.

The featured speakers used a stirred suspension bioreactor system to create an optimal environment for cell growth and differentiation. This enabled them to create a unified differentiation protocol that can be applied to a variety of hiPSCs (patient and control lines) with high cardiomyocyte content and reduced batch-to-batch variability. Using a wide array of cardiac disease modeling assays, they then confirmed high reproducibility of cryo-preserved hiPSC-derived cardiomyocytes.

Join this webinar to learn about optimizing the growth and differentiation of human induced pluripotent stem cells (hiPSCs) into cardiomyocytes and enhancing cardiac disease modeling.

Join Maksymilian Prondzynski, PhD, Instructor, The Department of Cardiology, Boston Children’s Hospital and Harvard Medical School, for the live webinar on Tuesday, June 27, 2023, at 9am CDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Producing High Quality CRISPR-Cas9 Edited hiPSCs for Cardiac Disease Modeling.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: